health sectionhealth sectionEndometrial cancer originates in the lining of the uterus. As the development and spread of endometrial cancer is largely reliant on the presence of estrogen in the body, hormone therapy is normally administered following surgery to reduce the possibility of cancer recurring in the future.
Aromasin is a steroid that lowers the risk of recurring breast cancer and increases the chance of survival. It restrains estrogen levels by inhibiting aromatase located in fatty tissues like the breasts. Aromatase converts pre-estrogen into an active estrogen for women who have just undergone chemotherapy for breast cancer; aromasin combats this effect.
Breast cancer occurs when cells in the breast tissue begin growing uncontrollably. Because breast cells can grow in response to certain hormones, one method of treating breast cancer is to block the effects of these hormones. Hormone therapy is centered on blocking the effects of estrogen and progesterone through surgery or medication.
